These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
767 related articles for article (PubMed ID: 23134976)
1. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials. Lu Z; Wen F; Guo Q; Liang H; Mao X; Sun H Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976 [TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Wang W; Shi J; Xie WF Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507 [TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. Peng ZW; Zhang YJ; Chen MS; Xu L; Liang HH; Lin XJ; Guo RP; Zhang YQ; Lau WY J Clin Oncol; 2013 Feb; 31(4):426-32. PubMed ID: 23269991 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors]. Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma. Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. Ni JY; Liu SS; Xu LF; Sun HL; Chen YT World J Gastroenterol; 2013 Jun; 19(24):3872-82. PubMed ID: 23840128 [TBL] [Abstract][Full Text] [Related]
8. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Kagawa T; Koizumi J; Kojima S; Nagata N; Numata M; Watanabe N; Watanabe T; Mine T; Cancer; 2010 Aug; 116(15):3638-44. PubMed ID: 20564097 [TBL] [Abstract][Full Text] [Related]
9. [Clinical outcomes of radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: a single-center experience]. Lin JJ; Wu W; Jiang XF; Jin XJ; Lu LJ; Bao LW Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):144-7. PubMed ID: 23714672 [TBL] [Abstract][Full Text] [Related]
10. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation]. Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809 [TBL] [Abstract][Full Text] [Related]
11. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. Cheng BQ; Jia CQ; Liu CT; Fan W; Wang QL; Zhang ZL; Yi CH JAMA; 2008 Apr; 299(14):1669-77. PubMed ID: 18398079 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinomas Compared with Radiofrequency Ablation Alone: A Time-to-Event Meta-Analysis. Wang X; Hu Y; Ren M; Lu X; Lu G; He S Korean J Radiol; 2016; 17(1):93-102. PubMed ID: 26798221 [TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis. Li L; Tian J; Liu P; Wang X; Zhu Z Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950 [TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma. Peng ZW; Chen MS Oncology; 2013; 84 Suppl 1():40-3. PubMed ID: 23428857 [TBL] [Abstract][Full Text] [Related]
15. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis. Jiang C; Cheng G; Liao M; Huang J World J Surg Oncol; 2021 Mar; 19(1):81. PubMed ID: 33741001 [TBL] [Abstract][Full Text] [Related]
16. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients. Huang ZM; Li W; Li S; Gao F; Zhou QM; Wu FM; He N; Pan CC; Xia JC; Wu PH; Zhao M J Immunother; 2013 Jun; 36(5):287-93. PubMed ID: 23719239 [TBL] [Abstract][Full Text] [Related]
17. Meta-analysis on radiofrequency ablation in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma. Cao JH; Zhou J; Zhang XL; Ding X; Long QY J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):692-700. PubMed ID: 25318879 [TBL] [Abstract][Full Text] [Related]
18. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm]. Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266 [TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis. Chen QW; Ying HF; Gao S; Shen YH; Meng ZQ; Chen H; Chen Z; Teng WJ Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):309-314. PubMed ID: 26428660 [TBL] [Abstract][Full Text] [Related]
20. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors]. Fan WZ; Yang JY; Lü MD; Xie XY; Yin XY; Huang YH; Kuang M; Li HP; Xu HX; Li JP Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(31):2190-4. PubMed ID: 22094036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]